Source: ERS Lung Science Conference 2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helen Stölting, United Kingdom. PP113 – Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood?. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood? Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Hepatocyte growth factor prevents airway remodelling in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 The epidermal growth factor receptor mediates allergic airway remodelling in the rat Source: Eur Respir J 2008; 32: 1213-1223 Year: 2008 Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 How important is airway remodelling in childhood for later life? Source: Annual Congress 2004 - Remodelling in children: myths and facts in asthma Year: 2004 Gene polymorphism of epidermal growth factor receptor (EGFR) and airway hyperresponsiveness (AHR) in young allergic subjects without respiratory symptoms Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Proto-oncogenes expression in airway remodelling in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Fibroblast growth factor 23 and Klotho contribute to airway inflammation Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018 Year: 2018 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Transforming growth factor alpha produces airway remodelling and reduces airway distensibility Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Growth factor treatment for asthma by restoration of epithelial barrier function Source: Annual Congress 2008 - New treatments for asthma Year: 2008 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Source: Eur Respir J 2008; 31: 714-724 Year: 2008